Atlas Trials

Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

Clinical trial NCT05809687 · WITHDRAWN

Trial details

NCT number
NCT05809687
Sponsor
Dongkwang Pharm. Co., Ltd.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Dyslipidemias
Start date
2025-01-01
Primary completion
2026-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.